Cholesterol-induced LRP3 downregulation promotes cartilage degeneration in osteoarthritis by targeting SDC4

Chenxi Cao,Yuanyuan Shi,Zhang Xin,Qi Li,Jiaohao Zhang,Fengyuan Zhao,Qingyang Meng,Wenli Dai,Zhenlong Liu,Duan Xiaoning,Jiying Zhang,Xin Fu,Jin Cheng,Hu Xiaoqing,Yingfang Ao
DOI: https://doi.org/10.21203/rs.3.rs-309414/v1
2021-01-01
Abstract:Abstract Emerging evidence suggests that osteoarthritis (OA) is associated with high cholesterol levels. However, the specific mechanism remains unclear. Here, we found that cholesterol metabolism-related gene, LRP3 (low-density lipoprotein receptor-related protein 3) is significantly reduced in high-cholesterol diet mouse’s cartilage. By using global Lrp3−/− mice in vivo and LRP3 lentiviral vector-transduced chondrocytes in vitro, we identified that LRP3 positively regulated chondrocyte extracellular matrix metabolism, and its deficiency aggravated the degeneration of OA cartilage. Regardless of diet, LRP3 overexpression in cartilage attenuated anterior cruciate ligament transection (ACLT)-induced OA progression in rats. Furthermore, LRP3 knockdown upregulated syndecan-4 (SDC4) expression by activating the Ras signaling pathway. We identified SDC4 as a downstream molecular target of LRP3 in OA pathogenesis. Together, these findings suggest that the cholesterol-LRP3-SDC4 axis plays critical roles in the OA development, and the LRP3 gene therapy may provide a new therapeutic regimen for OA treatment.
What problem does this paper attempt to address?